Aimmune Therapeutics, Inc. EBITDA 2015-2020 | AIMT
Aimmune Therapeutics, Inc. ebitda from 2015 to 2020. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Aimmune Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2019 | $-247 |
| 2018 | $-215 |
| 2017 | $-132 |
| 2016 | $-80 |
| 2015 | $-36 |
| 2014 | $-11 |
| 2013 | $-5 |
| Aimmune Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2020-06-30 | $-65 |
| 2020-03-31 | $-84 |
| 2019-12-31 | $-66 |
| 2019-09-30 | $-64 |
| 2019-06-30 | $-63 |
| 2019-03-31 | $-55 |
| 2018-12-31 | $-58 |
| 2018-09-30 | $-53 |
| 2018-06-30 | $-54 |
| 2018-03-31 | $-50 |
| 2017-12-31 | $-41 |
| 2017-09-30 | $-32 |
| 2017-06-30 | $-33 |
| 2017-03-31 | $-26 |
| 2016-12-31 | $-25 |
| 2016-09-30 | $-22 |
| 2016-06-30 | $-18 |
| 2016-03-31 | $-15 |
| 2015-12-31 | $-16 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-7 |
| 2015-03-31 | $-3 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-3 |
